Company intelligence / Profile preview

Star Lake Bioscience

Zhaoqing, Guangdong, Chinastarlake.com.cn ↗

Ownership: Private
Employees: ~9293
Development stage: Other

Overview

Star Lake Bioscience is a leading Chinese manufacturer of biochemical raw materials, pharmaceutical intermediates, and feed additives. Its products are widely used in the treatment of chronic hepatitis, heart disease, leukopenia/thrombocytopenia, and as nutritional supplements in animal feed. The company’s portfolio includes both active pharmaceutical ingredients (APIs) such as inosine and ribavirin as well as finished dosage forms like adefovir dipivoxil tablets for hepatitis B.

Therapeutic areas: OphthalmologyHematologyCardiovascularInfectious Diseases
Modalities: Small moleculeAmino acidNucleoside analog
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Star Lake Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Star Lake Bioscience.

Explore the full profile